The underlying hypothesis of the proposed studies is that the ability of activated Cdc42 to induce anchorage-independent growth derives from its effects on cyclin A. Thus, the proposal focuses on identifying the mechanisms by which Cdc42 induces anchorage-independent growth and how it stimulates cyclin A expression in the absence of mitogens. The application contains three specific aims. The first will be to determine the mechanism by which Cdc42 activates the cyclin A promoter. Here the goal will be to identify and characterize the cis- and trans-acting factors that confer Cdc42-responsiveness to the cyclin A promoter.
The second aim i s to identify Cdc42 effectors that are responsible for mediating cyclin A induction and anchorage-independent growth.
The third aim will be to establish whether Cdc42V12 effectors are critical mediators of adhesion-dependent signals during the normal proliferative response. The importance of these experiments is to establish whether similar pathways are used by a transforming Cdc42 mutant and wild type Cdc42 under normal physiological conditions.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Research Project (R01)
Project #
Application #
Study Section
Cell Development and Function Integrated Review Group (CDF)
Program Officer
Woodhouse, Elizabeth
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Pennsylvania
Anatomy/Cell Biology
Schools of Medicine
United States
Zip Code
Pringle, L M; Young, R; Quick, L et al. (2012) Atypical mechanism of NF-?B activation by TRE17/ubiquitin-specific protease 6 (USP6) oncogene and its requirement in tumorigenesis. Oncogene 31:3525-35
Erickson-Johnson, Michele R; Chou, Margaret M; Evers, Barbara R et al. (2011) Nodular fasciitis: a novel model of transient neoplasia induced by MYH9-USP6 gene fusion. Lab Invest 91:1427-33
Ye, Y; Pringle, L M; Lau, A W et al. (2010) TRE17/USP6 oncogene translocated in aneurysmal bone cyst induces matrix metalloproteinase production via activation of NF-kappaB. Oncogene 29:3619-29
Lau, Alan W; Pringle, Lashon M; Quick, Laura et al. (2010) TRE17/ubiquitin-specific protease 6 (USP6) oncogene translocated in aneurysmal bone cyst blocks osteoblastic maturation via an autocrine mechanism involving bone morphogenetic protein dysregulation. J Biol Chem 285:37111-20
Holloway, Beth A; Gomez de la Torre Canny, Sol; Ye, Ying et al. (2009) A novel role for MAPKAPK2 in morphogenesis during zebrafish development. PLoS Genet 5:e1000413
Lau, Alan W; Chou, Margaret M (2008) The adaptor complex AP-2 regulates post-endocytic trafficking through the non-clathrin Arf6-dependent endocytic pathway. J Cell Sci 121:4008-17
Robertson, Sarah E; Setty, Subba Rao Gangi; Sitaram, Anand et al. (2006) Extracellular signal-regulated kinase regulates clathrin-independent endosomal trafficking. Mol Biol Cell 17:645-57
Shen, Chuanlu; Ye, Ying; Robertson, Sarah E et al. (2005) Calcium/calmodulin regulates ubiquitination of the ubiquitin-specific protease TRE17/USP6. J Biol Chem 280:35967-73
Martinu, Lenka; Masuda-Robens, Jeffrey M; Robertson, Sarah E et al. (2004) The TBC (Tre-2/Bub2/Cdc16) domain protein TRE17 regulates plasma membrane-endosomal trafficking through activation of Arf6. Mol Cell Biol 24:9752-62
Baumeister, Mark A; Martinu, Lenka; Rossman, Kent L et al. (2003) Loss of phosphatidylinositol 3-phosphate binding by the C-terminal Tiam-1 pleckstrin homology domain prevents in vivo Rac1 activation without affecting membrane targeting. J Biol Chem 278:11457-64

Showing the most recent 10 out of 14 publications